Drug General Information
Drug ID	D08MHD
Former ID	DIB002510
Drug Name	E-2609
Synonyms	Beta secretase inhibitor (Alzheimer's disease), Eisai
Indication	Alzheimer disease [ICD9: 331; ICD10:G30]		Phase 2	[525035]
Company	Eisai Co Ltd
Structure		Download 2D MOL 3D MOL
Target and Pathway
Target(s)	Beta-secretase	Target Info	Inhibitor	[544424]
References
Ref 525035	ClinicalTrials.gov (NCT02322021) Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild Dementia Due to Alzheimer's Disease. U.S. National Institutes of Health.
Ref 544424	Targeting the beta secretase BACE1 for Alzheimer's disease therapy. Lancet Neurol. 2014 March; 13(3): 319-329.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.